LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K012243
    Device Name
    MCC URICHECK ASSAYED LIQUID URINE MULTICONSTITUENT CONTROL
    Manufacturer
    HEMATRONIX, INC.
    Date Cleared
    2001-08-20

    (34 days)

    Product Code
    JJY
    Regulation Number
    862.1660
    Type
    Traditional
    Panel
    Clinical Chemistry
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    MCC™ URICHECK™ from HEMATRONIX, INC. is a synthetic matrix based assayed liquid urine multi-constituent control intended to monitor the precision and accuracy of instrument used in the clinical laboratory environment. MCC™ URICHECK™ is intended to monitor the precision and accuracy of instrument used in the methods when run as a patient sample and is ready to use. Expected ranges for the chemical and physical properties of MCC™ URICHECK™ have been established for monitoring or quantitative "constituents" used in routine clinical chemistry analysis.

    Device Description

    MCC™ URICHECK™ Assayed Liquid Urine Multi-Constituent Control is a synthetic matrix based assayed liquid urine multi-constituent control.

    AI/ML Overview

    This document pertains to a 510(k) premarket notification for a medical device called the "MCC™ URICHECK™ Assayed Liquid Urine Multi-constituent Control." It is a regulatory letter from the FDA, and as such, it does not contain the acceptance criteria or a study proving the device meets those criteria.

    The letter explicitly states: "We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent to devices marketed in interstate commerce prior to May 28, 1976..." This indicates that the device has been cleared based on demonstrating substantial equivalence to a predicate device, rather than through a new clinical effectiveness study demonstrating specific performance against acceptance criteria.

    Therefore, I cannot extract the requested information regarding acceptance criteria, device performance, sample sizes, expert involvement, adjudication, MRMC studies, standalone performance, or ground truth details from this document.

    The document only provides:

    • Device Name: MCC™ URICHECK™ Assayed Liquid Urine Multi-constituent Control
    • Intended Use: To monitor the precision and accuracy of instruments used in methods for chemistry analysis in a clinical laboratory environment by being run as a patient sample.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1